Classifications

• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
  • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
  • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
  • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P25/00—Drugs for disorders of the nervous system
  • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
  • C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
  • C07D219/08—Nitrogen atoms
  • C07D219/10—Nitrogen atoms attached in position 9
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
  • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
  • C07D221/04—Ortho- or peri-condensed ring systems
  • C07D221/06—Ring systems of three rings
  • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered

Landscapes

• Chemical & Material Sciences (AREA)
• Organic Chemistry (AREA)
• Health & Medical Sciences (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Biomedical Technology (AREA)
• Neurology (AREA)
• Neurosurgery (AREA)
• Pharmacology & Pharmacy (AREA)
• Veterinary Medicine (AREA)
• General Chemical & Material Sciences (AREA)
• Medicinal Chemistry (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Psychiatry (AREA)
• Hospice & Palliative Care (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Nitrogen Condensed Heterocyclic Rings (AREA)
• Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
• Other In-Based Heterocyclic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Pyridine Compounds (AREA)
• Hydrogenated Pyridines (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
• Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=23025549

Family Applications (1)

Country Status (18)

Families Citing this family (10)

Family Cites Families (5)

• 1988
  • 1988-11-09 US US07/269,038 patent/US4868177A/en not_active Expired - Lifetime
• 1989
  • 1989-11-06 ES ES89120463T patent/ES2059677T3/es not_active Expired - Lifetime
  • 1989-11-06 DE DE68918402T patent/DE68918402T2/de not_active Expired - Fee Related
  • 1989-11-06 EP EP89120463A patent/EP0368188B1/en not_active Expired - Lifetime
  • 1989-11-06 AT AT89120463T patent/ATE111899T1/de not_active IP Right Cessation
  • 1989-11-07 FI FI895288A patent/FI895288A7/fi not_active Application Discontinuation
  • 1989-11-07 IL IL92233A patent/IL92233A0/xx unknown
  • 1989-11-07 KR KR1019890016064A patent/KR900007808A/ko not_active Withdrawn
  • 1989-11-07 NZ NZ231293A patent/NZ231293A/xx unknown
  • 1989-11-07 AU AU44423/89A patent/AU623701B2/en not_active Ceased
  • 1989-11-08 IE IE359289A patent/IE64499B1/en not_active IP Right Cessation
  • 1989-11-08 JP JP1288977A patent/JPH03153667A/ja active Pending
  • 1989-11-08 PT PT92234A patent/PT92234B/pt not_active IP Right Cessation
  • 1989-11-08 ZA ZA898498A patent/ZA898498B/xx unknown
  • 1989-11-08 DK DK557189A patent/DK166620B1/da not_active IP Right Cessation
  • 1989-11-08 NO NO89894445A patent/NO894445L/no unknown
  • 1989-11-08 CA CA002002531A patent/CA2002531A1/en not_active Abandoned
  • 1989-11-08 HU HU895830A patent/HU208530B/hu not_active IP Right Cessation

Also Published As

Similar Documents